Common Pain Relievers Like Ibuprofen and Acetaminophen May Work Partly Through the Endocannabinoid System
NSAIDs, paracetamol, and pyrazolones may enhance pain relief partly by boosting endocannabinoid levels or interacting with cannabinoid signaling.
Quick Facts
What This Study Found
These analgesics interact with the ECS: enhancing endocannabinoid levels, influencing CB1/CB2 signaling, and modulating FAAH and MAGL enzymes, providing synergistic analgesic effects.
Key Numbers
Three analgesic classes reviewed. Multiple ECS mechanisms identified. FAAH and MAGL modulation confirmed.
How They Did This
Review of pharmacological evidence on non-opioid analgesic-ECS interactions.
Why This Research Matters
Understanding cannabinoid system involvement in everyday painkillers opens doors to combination therapies reducing opioid dependence.
The Bigger Picture
The endocannabinoid system is a fundamental pain regulation system that existing drugs already exploit.
What This Study Doesn't Tell Us
Review format. Much evidence preclinical.
Questions This Raises
- ?Could combining NSAIDs with cannabinoids produce superior pain relief?
- ?Does this explain NSAID efficacy for non-inflammatory pain?
Trust & Context
- Key Stat:
- Evidence Grade:
- Comprehensive pharmacological review but clinical evidence still developing.
- Study Age:
- 2025 review of ECS interactions with non-opioid analgesics.
- Original Title:
- The role of the endocannabinoid system in the mechanism of action of nonopioid analgesics.
- Published In:
- European journal of pharmacology, 1003, 177946 (2025)
- Database ID:
- RTHC-07837
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Do painkillers like ibuprofen affect the endocannabinoid system?
Yes. They boost endocannabinoid levels and interact with cannabinoid receptors.
Could cannabinoids plus painkillers work better?
Synergistic potential exists for more effective pain treatments.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07837APA
Unterspann, Marcela; Lapka, Marek; Charalambous, Chrysostomos; Sliva, Jiri. (2025). The role of the endocannabinoid system in the mechanism of action of nonopioid analgesics.. European journal of pharmacology, 1003, 177946. https://doi.org/10.1016/j.ejphar.2025.177946
MLA
Unterspann, Marcela, et al. "The role of the endocannabinoid system in the mechanism of action of nonopioid analgesics.." European journal of pharmacology, 2025. https://doi.org/10.1016/j.ejphar.2025.177946
RethinkTHC
RethinkTHC Research Database. "The role of the endocannabinoid system in the mechanism of a..." RTHC-07837. Retrieved from https://rethinkthc.com/research/unterspann-2025-the-role-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.